March 12, 2020 10:23 AM EDT

CureVac founder back at the helm; Merck extends immunomodulatory drug discovery program with Sutro

→ Daniel Menichella, the CEO of CureVac and the face of its recent endeavors to develop an mRNA vaccine against Covid-19, is

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Cure­Vac founder back at the helm; Mer­ck ex­tends im­munomod­u­la­to­ry drug dis­cov­ery pro­gram with Sutro